43 reports of this reaction
2.3% of all CEFPODOXIME PROXETIL reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for CEFPODOXIME PROXETIL, manufactured by Amici Pharmaceuticals, LLC.. There are 43 FDA adverse event reports linking CEFPODOXIME PROXETIL to FATIGUE. This represents approximately 2.3% of all 1,861 adverse event reports for this drug.
Patients taking CEFPODOXIME PROXETIL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for CEFPODOXIME PROXETIL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for CEFPODOXIME PROXETIL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 43 FDA reports for CEFPODOXIME PROXETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.3% of all adverse event reports for CEFPODOXIME PROXETIL, making it a notable side effect.
If you experience fatigue while taking CEFPODOXIME PROXETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.